India Artesunate Market to grow at a steady rate During the Forecast Period

Growing prevalence of malaria is expected to drive the growth of India artesunate market.

According to TechSci Research report, “India Artesunate Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Injection), By Route of Administration (Oral v/s Intravenous), By Application (Malaria, Parasitic Infections, COVID-19, Others), By Distribution Channel (Online v/s Offline), By Company, By Region, Forecast & Opportunities, FY2026”, the India artesunate market is expected to grow at a steady rate during the forecast period on account of the supportive government policies and schemes such as the launch of 6940 crores production linked incentive scheme for the manufacturing of 53 API products in India. This will in turn reduce the dependency on imports and also improve the status of domestic players. Also, this is in relevance with the China plus one strategy, Self-Sufficient India strategy, Make in India and Vocal for Local strategy. Additionally, the extensive use of drug as an anti-malarial drug and against several parasitic infections is further expected to fuel the market growth through FY2026. Besides, the drug is being used as an alternative to hydroxychloroquine in the treatment of COVID-19. This in turn is expected to create lucrative opportunities for the market growth during the forecast period. However, side-effects such as loss of appetite, nausea, dizziness, among others can hamper the market growth over the next few years. Furthermore, other side-effects commonly observed due to consumption of artesunate include rashes, seizures, hives, neuropsychiatric reactions, among others. These are further expected to restrict the market growth in the next five years.

Browse 180 market data Figures spread through 130 Pages and an in-depth TOC on“Global Patient Circuit Market”

https://www.techsciresearch.com/report/india-artesunate-market/5137.html

The India artesunate market is segmented based on source, form, route of administration, distribution channel, application, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. The contract manufacturing organizations is expected to witness significant growth during the forecast period since companies have started outsourcing the production of drugs to these organizations so that they can focus on research & development of drugs. Additionally, these organizations fulfil the customer requirement in a lesser time frame and offer competitive pricing to the customers. They are also capable enough to fulfil the bulk requirements of their clients. Based on form, the market can be bifurcated into tablet and injection. The injection segment is expected to dominate the market since it is a preferred choice of administering the medication over quinine for treatment of severe malaria. Based on route of administration, the market can be divided into oral and intravenous. The intravenous route is expected to dominate the market since the most preferred form of administration of this medication is through injections hence driving the growth of intravenous segment. The intravenous route provides a bioavailability of 100% and desired blood concentrations can be easily achieved through this mode of drug administration. Based on application, the market can be categorized into malaria, parasitic infections, covid-19 and others. The malaria segment is expected to dominate the market since artesunate is a potential anti-malarial drug which is used in the treatment of malaria. It is often used in combination with several other antimalarial drugs for treatment of malaria in both adults and pediatrics.

Solara Active Pharma Sciences Limited, Gonane Pharma, Cipla Limited, Mangalam Drugs & Organics Limited, Nishchem International Pvt. Ltd., Vaishali Pharma Limited, Vital Laboratories Private Limited, Actiza Pharmaceutical Pvt. Ltd, Systacare Remedies, Prism Industries Ltd. and others are some of the leading players operating in India artesunate market.

 Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5137

Customers can also request for 10% free customization on this report.

“India Artesunate market is expected to witness growth during the forecast period on account of the use of the drug as a potential treatment for COVID-19. Artesunate has anti-inflammatory activity and endocytosis inhibition mechanism like chloroquine. Additionally, artesunate improves the symptoms of COVID-19 in a lesser duration and also reduces the hospital stay for the patients.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.

“India Artesunate Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Injection), By Route of Administration (Oral v/s Intravenous), By Application (Malaria, Parasitic Infections, COVID-19, Others), By Distribution Channel (Online v/s Offline), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India artesunate market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India artesunate market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]